AGOSTINELLI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 12.413
AS - Asia 8.630
EU - Europa 8.392
SA - Sud America 662
AF - Africa 628
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 30.739
Nazione #
US - Stati Uniti d'America 12.293
SG - Singapore 2.864
CN - Cina 2.614
GB - Regno Unito 2.265
IT - Italia 1.363
VN - Vietnam 1.323
DE - Germania 1.189
SE - Svezia 991
HK - Hong Kong 711
IN - India 591
RU - Federazione Russa 525
BR - Brasile 472
UA - Ucraina 412
FR - Francia 343
IE - Irlanda 329
ZA - Sudafrica 209
NL - Olanda 172
EE - Estonia 153
CI - Costa d'Avorio 152
CH - Svizzera 150
TG - Togo 129
FI - Finlandia 121
KR - Corea 119
JP - Giappone 113
AR - Argentina 93
BG - Bulgaria 74
CA - Canada 64
AT - Austria 61
ID - Indonesia 60
JO - Giordania 59
NG - Nigeria 48
BE - Belgio 46
SC - Seychelles 41
MX - Messico 40
PL - Polonia 39
IR - Iran 31
EC - Ecuador 28
HR - Croazia 27
LU - Lussemburgo 25
CL - Cile 24
LB - Libano 24
BD - Bangladesh 23
TR - Turchia 20
GR - Grecia 18
CO - Colombia 16
ES - Italia 16
UZ - Uzbekistan 15
LT - Lituania 14
EG - Egitto 10
CZ - Repubblica Ceca 9
PY - Paraguay 9
MY - Malesia 8
PE - Perù 8
IQ - Iraq 7
PH - Filippine 7
RO - Romania 7
AU - Australia 6
DO - Repubblica Dominicana 6
PK - Pakistan 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
UY - Uruguay 6
HU - Ungheria 5
IL - Israele 5
MA - Marocco 5
AL - Albania 4
DK - Danimarca 4
DZ - Algeria 4
KE - Kenya 4
NP - Nepal 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
LV - Lettonia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
HN - Honduras 2
KH - Cambogia 2
KW - Kuwait 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
RS - Serbia 2
SA - Arabia Saudita 2
UG - Uganda 2
ZM - Zambia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
Totale 30.713
Città #
Southend 2.002
Singapore 1.803
Fairfield 1.437
Ashburn 1.272
Chandler 899
Woodbridge 713
Hong Kong 705
Houston 699
Wilmington 664
Seattle 610
Princeton 546
Cambridge 502
Ann Arbor 456
Beijing 415
Dong Ket 401
Santa Clara 376
Dublin 328
Bologna 324
Boardman 297
Hefei 287
Nanjing 234
Westminster 211
Ho Chi Minh City 209
Jacksonville 196
Padova 182
Los Angeles 166
Abidjan 152
Hanoi 149
New York 142
Bremen 137
Berlin 134
Lomé 128
Bern 126
Dallas 121
Jinan 119
Saint Petersburg 114
Seoul 114
Milan 112
Tokyo 106
Buffalo 103
Shenyang 96
Helsinki 92
Redondo Beach 90
Redmond 86
Nanchang 85
Hebei 75
Changsha 74
Sofia 74
San Diego 73
Hyderabad 67
London 67
Mülheim 64
Tianjin 62
Amman 59
Medford 59
São Paulo 57
Jiaxing 56
Guangzhou 55
Zhengzhou 54
Hangzhou 52
Falls Church 51
Abeokuta 46
Brussels 46
Munich 43
Chicago 41
Haikou 40
Redwood City 40
Turin 39
Yubileyny 39
Frankfurt am Main 38
Rome 36
Vienna 36
Dearborn 35
Jakarta 35
Phoenix 35
Taizhou 35
Norwalk 33
San Venanzo 33
Haiphong 32
Shanghai 32
Des Moines 30
Toronto 30
Ningbo 29
Olalla 29
Nuremberg 28
Bengaluru 27
Taiyuan 27
Warsaw 27
Falkenstein 26
Amsterdam 23
Mahé 22
Chennai 20
Orem 20
Verona 20
Fremont 19
Shenzhen 19
Wuhan 19
Bühl 18
Da Nang 18
Mexico City 18
Totale 20.322
Nome #
ANALYSIS OF THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA REVEALS MUTATIONAL ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DIFFERENTIATION 280
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 266
Biology and treatment of follicular lymphoma. 264
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 248
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 247
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 233
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 231
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 226
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 221
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma – Authors' reply 216
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 208
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 207
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 206
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 203
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 200
IFI16 expression is related to selected transcription factors during B-cell differentiation 196
Expression of CD52 in peripheral T-cell lymphoma. 192
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 187
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. 185
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report 184
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 182
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 181
RALE051: a novel established cell line of sporadic Burkitt lymphoma 179
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 178
Histopathology of B-cell chronic lymphocytic leukemia. 174
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). 174
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 174
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. 172
CD30 expression in peripheral T-cell lymphomas 172
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 170
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 168
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 168
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 168
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 166
Anaplastic Large Cell Lymphoma: a critical reappraisal 165
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 165
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. 163
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES 163
BCL10 down-regulation in peripheral T-cell lymphomas. 160
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 160
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 160
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 159
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 159
Photodynamic therapy: An option in mycosis fungoides 158
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 157
A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp. 157
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 157
Pathobiology of hodgkin lymphoma. 157
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 156
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis 156
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 155
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 155
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. 154
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 154
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 154
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 152
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 152
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 150
Pathobiology of anaplastic large cell lymphoma. 150
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 148
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. 146
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 146
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 144
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 144
Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder 143
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 143
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups 142
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 142
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 141
Pathobiology of ALK-negative anaplastic large cell lymphoma. 141
Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report. 139
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 139
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 138
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 138
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 137
Prognostic markers in peripheral T-cell lymphoma. 136
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. 136
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. 136
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 136
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 135
Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long term follow up and literature review 135
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 134
Cutaneous adverse-events in patients treated with Ibrutinib 134
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 133
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 132
Alopecia areata-like mycosis fungoides: Lions for lambs 132
Storia di una cellula. 131
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 131
Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda. 131
Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study 129
Peripheral T-cell lymphomas not otherwise specified correspond to distinct mature T-cell populations basing on the global gene expression profile. 129
Granulomatous tattoo reaction in a nivolumab-treated patient 129
Integrated molecular profilino for the diagnosis and classification of peripheral T-cell lymphomas. 128
Primary cutaneous lymphomas: a reprisal 128
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters 128
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 128
Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. 127
Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. 127
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 125
Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies. 125
Totale 16.300
Categoria #
all - tutte 92.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.935 0 0 0 0 0 146 61 146 371 146 155 910
2021/20224.099 314 151 240 284 436 242 80 282 208 351 889 622
2022/20234.424 539 603 251 599 335 334 132 243 711 104 320 253
2023/20241.240 64 229 116 105 109 227 89 82 43 87 36 53
2024/20254.668 232 878 447 368 664 232 404 144 55 229 176 839
2025/20265.943 826 975 1.090 1.010 1.405 637 0 0 0 0 0 0
Totale 31.428